Correlation Between ZyVersa Therapeutics and 180 Life
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and 180 Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and 180 Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and 180 Life Sciences, you can compare the effects of market volatilities on ZyVersa Therapeutics and 180 Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of 180 Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and 180 Life.
Diversification Opportunities for ZyVersa Therapeutics and 180 Life
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ZyVersa and 180 is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and 180 Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 180 Life Sciences and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with 180 Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 180 Life Sciences has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and 180 Life go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and 180 Life
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the 180 Life. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 2.1 times less risky than 180 Life. The stock trades about -0.11 of its potential returns per unit of risk. The 180 Life Sciences is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 2,052 in 180 Life Sciences on August 29, 2024 and sell it today you would lose (1,832) from holding 180 Life Sciences or give up 89.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. 180 Life Sciences
Performance |
| Timeline |
| ZyVersa Therapeutics |
| 180 Life Sciences |
ZyVersa Therapeutics and 180 Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and 180 Life
The main advantage of trading using opposite ZyVersa Therapeutics and 180 Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, 180 Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 180 Life will offset losses from the drop in 180 Life's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| 180 Life vs. Eliem Therapeutics | 180 Life vs. Scpharmaceuticals | 180 Life vs. Milestone Pharmaceuticals | 180 Life vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |